The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease

The Role of Interleukin-33 in Patients with Mild Cognitive Impairment and Alzheimer's Disease - Liang et al. 2020

The Role of Interleukin-33 in Patients with Mild Cognitive Impairment and Alzheimer's Disease

© 2020 Liang, Su, Tsai, Lee, Chu, Yeh, Su, Lin, Lin, Chu, Tsai and Yang

Alzheimer's Research & Therapy

Previous
Previous

The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

Next
Next

The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease